TickerFacts.

NeoGenomics Inc (NEO): Total Liabilities

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2015-12-31, 2017-12-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$523.27M
As of 2025-12-31
$566.51M
As of 2026-06-30
-11.0%
3-year compound annual growth
+12.2%
5-year compound annual growth
$761.50M2010-12-31: $10.52M2011-12-31: $14.05M2012-12-31: $20.86M2013-12-31: $18.20M2014-12-31: $20.70M2015-12-31: $113.17M2016-12-31: $150.52M2017-12-31: $139.88M2018-12-31: $184.57M2019-12-31: $202.10M2020-12-31: $294.04M2021-12-31: $761.50M2022-12-31: $742.01M2023-12-31: $739.69M2024-12-31: $735.70M2025-12-31: $523.27M$523.27M
2010-12-31 Total Liabilities (USD) 2025-12-31
Period endedTotal LiabilitiesChange YoYSource filing
2025-12-31$523.27M-28.9%2026-02-17, Balance as of period end
2024-12-31$735.70M-0.5%2026-02-17, Balance as of period end
2023-12-31$739.69M-0.3%2025-02-18, Balance as of period end
2022-12-31$742.01M-2.6%2024-02-20, Balance as of period end
2021-12-31$761.50M+159.0%2023-02-24, Balance as of period end
2020-12-31$294.04M+45.5%2022-02-25, Balance as of period end
2019-12-31$202.10M+9.5%2021-02-25, Balance as of period end
2018-12-31$184.57M+32.0%2020-02-28, Balance as of period end
2017-12-31$139.88Mn/c2019-02-26, Balance as of period end
2016-12-31$150.52M+33.0%2018-03-13, Balance as of period end
2015-12-31$113.17Mn/c2017-03-14, Balance as of period end
2014-12-31$20.70M+13.7%2016-04-18, Balance as of period end
2013-12-31$18.20M-12.7%2015-03-03, Balance as of period end
2012-12-31$20.86M+48.4%2014-02-24, Balance as of period end
2011-12-31$14.05M+33.6%2013-02-21, Balance as of period end
2010-12-31$10.52Mn/a2012-03-12, Balance as of period end

Total Liabilities at similar companies

Companies with the same SEC industry code (Services-Testing Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal LiabilitiesChange YoY
NeoGenomics Inc (NEO)2025-12-31$523.27M-28.9%
UL Solutions Inc. (ULS)2025-12-31$1.63B-12.9%
20/20 Biolabs, Inc. (AIDX)2025-12-31$4.16M+99.9%
Hypha Labs, Inc. (FUNI)2025-09-30$2.51M+76.9%

Compare NEO, ULS, AIDX, FUNI side by side · Screen every company in Services-Testing Laboratories ↗